A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer
作者全名:"Xiao, Lei; Chen, Naifei; Pu, Chengfei; Zhao, Lingling; Li, Ning; Wang, Chang; Huang, Yusheng; Luo, Su-xia; Li, Xun; Yang, Zhenzhou; Bie, Jun; Zhu, Ruihong; Liang, Tingting; Wang, Yizhuo; Jia, Beibei; Chen, Dongqi; Wu, Zhao; Song, Yongping; Lu, Victor; Cui, Jiuwei"
作者地址:"Innovat Cellular Therapeut Co Ltd, Rockville, MD USA; First Hosp Jilin Univ, Stem Cell & Canc Ctr, Changchun, Peoples R China; Innovat Cellular Therapeut Co Ltd, Shanghai, Peoples R China; Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China; Henan Canc Hosp, Zhengzhou, Peoples R China; Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Dept Canc Ctr, Chongqing, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Dept Oncol, Chongqing, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Southwest Canc, Chongqing, Peoples R China; Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China; Chongqing Med Univ, Affiliated Hosp 2, Ctr Canc, Chongqing, Peoples R China; Nanchong Cent Hosp, Nanchong, Peoples R China; Innovat Cellular Therapeut, Shanghai, Peoples R China; First Hosp Jilin Univ, Canc Ctr, Dept Oncol, Changchun, Peoples R China"
通信作者:
来源:JOURNAL OF CLINICAL ONCOLOGY
ESI学科分类:CLINICAL MEDICINE
WOS号:WOS:001053772000751
JCR分区:Q1
影响因子:42.1
年份:2023
卷号:41
期号:16
开始页:
结束页:
文献类型:Meeting Abstract
关键词:
摘要:
基金机构:Innovative Cellular Therapeutics
基金资助正文:Innovative Cellular Therapeutics.